STAND. COM. REP. NO. 276

Honolulu, Hawaii

, 2019

RE: H.B. No. 665

H.D. 1

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirtieth State Legislature

Regular Session of 2019

State of Hawaii

Sir:

Your Committee on Health, to which was referred H.B. No. 665 entitled:

"A BILL FOR AN ACT RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM,"

begs leave to report as follows:

The purpose of this measure is to:

(1) Exempt health care providers from the requirement to consult the electronic prescription accountability system in cases where the patient is in an inpatient setting or in hospice care; and

(2) Clarify that an informed consent agreement is not required for patients whose prescriptions will be directly administered at a hospital while they are under the supervision of a health care provider.

The Department of Health, Hawaii Health Systems Corporation, The Queen's Health Systems, Hawai‘i Pacific Health, Healthcare Association of Hawaii, Hawaii Substance Abuse Coalition, Ohana Pacific Management Company, Inc., and O‘ahu County Committee on Legislative Priorities of the Democratic Party of Hawai‘i testified in support of this measure. The Hawaii Association for Justice testified in opposition to this measure. The Department of Public Safety, Kaiser Permanente, and Hawaii Medical Association provided comments.

Your Committee has amended this measure by:

(1) Changing the effective date to July 1, 2050, to promote further discussion; and

(2) Making technical, nonsubstantive amendments for clarity, consistency, and style.

Your Committee notes that Kaiser Permanente recommended amending this measure to include a limited post-operation exception with a short duration to support patient care when patients are most in need of pain management.

As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 665, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 665, H.D. 1, and be referred to your Committees on Judiciary and Consumer Protection & Commerce.

Respectfully submitted on behalf of the members of the Committee on Health,

____________________________

JOHN M. MIZUNO, Chair